Have a personal or library account? Click to login
Epidemiologic and Clinical Differences Between Classic and Hypertrophic Lichen Planus in Nigeria Cover

Epidemiologic and Clinical Differences Between Classic and Hypertrophic Lichen Planus in Nigeria

Open Access
|Nov 2019

References

  1. 1. Black MM. Lichen planus and lichenoid disorders. In: Champion RH, Burton JL, Ebling FJG, Rook AJ, Wilkinson DS. Textbook of dermatology. Vol. 3. 5th ed. Oxford: Blackwell Scientific Publications; 1992. p. 1675.
  2. 2. Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol. 1991;25(4):593-619.10.1016/0190-9622(91)70241-S1791218
  3. 3. Usatine RP, Tinitigan M. Diagnosis and treatment of lichen planus. Am Fam Physician. 2011:84(1):53-60.
  4. 4. Katta R. Lichen planus. Am Fam Physician. 2000;62(8): 1786. Erratum for: Am Fam Physician. 2000;61(11):3319-24.
  5. 5. Weston G, Payette M. Update on lichen planus and its clinical variants. Int J Womens Dermatol. 2015;1(3):140-9.10.1016/j.ijwd.2015.04.001541887528491978
  6. 6. Lukács J, Schliemann S, Elsner P. Lichen planus and lichenoid reactions as a systemic disease. Clin Dermatol. 2015;33(5):512-9.10.1016/j.clindermatol.2015.05.00126321396
  7. 7. Pickert A. Concise review of lichen planus and lichenoid dermatoses. Cutis. 2012;90(3):E1-3.
  8. 8. Jaime TJ, Jaime TJ, Guaraldi Bde M, Melo DF, Jeunon T, Lerer C. Disseminated hypertrophic lichen planus: relevant response to acitretin. An Bras Dermatol. 2011;86(4 Suppl 1):S96-9.10.1590/S0365-0596201100070002522068783
  9. 9. Alomari A, McNiff JM. The significance of eosinophils in hypertrophic lichen planus. J Cutan Pathol. 2014;41(4): 347-52.2432578010.1111/cup.1227524325780
  10. 10. Levandoski KA, Nazarian RM, Asgari MM. Hypertrophic lichen planus mimicking squamous cell carcinoma: the importance of clinicopathologic correlation. JAAD Case Rep. 2017;3(2):151-4.2837400110.1016/j.jdcr.2017.01.020536779028374001
  11. 11. Totonchy MB, Leventhal JS, Ko CJ, Leffell DJ. Hyper-trophic lichen planus and well-differentiated squamous cell carcinoma: a diagnostic conundrum. Dermatol Surg. 2018;44(11):1466-70.10.1097/DSS.000000000000146529360655
  12. 12. Dietert JB, Rabkin MS, Joseph AK. Squamous cell carcinoma versus hypertrophic lichen planus; a difficult differential diagnosis of great significance in approach to treatment. Dermatol Surg. 2017;43(2):297-9.10.1097/DSS.000000000000088628165351
  13. 13. Nnoruka EN. Lichen planus in African children: a study of 13 patients. Pediatr Dermatol. 2007:24(5):495-8.10.1111/j.1525-1470.2007.00501.x17958794
  14. 14. Alabi GO, Akinsanya TB. Lichen planus in tropical Africa. Trop Geogr Med. 1981;33(2):143-7.
  15. 15. Daramola OO, Ogunbiyi AO, George AO. Lichen planus following hepatitis B vaccination in an African girl. Trop Doct. 2002;32(2):117-8.10.1177/00494755020320022711933900
  16. 16. Daramola OO, Ogunbiyi AO, George AO. Evaluation of clinical types of cutaneous lichen planus in anti-hepatitis C virus seronegative and seropositive Nigerians patients. Int J Dermatol. 2003;42(12):933-5.10.1111/j.1365-4632.2003.01715.x
  17. 17. Daramola OO, George AO, Ogunbiyi AO. Hepatitis C virus and lichen planus in Nigerians: any relationship? Int J Dermatol. 2002;41(4):217-9.10.1046/j.1365-4362.2002.01465.x
  18. 18. Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen carrier acceptor. J Clin Pathol. 1969;22(2):246-50.10.1136/jcp.22.2.246-b
  19. 19. Searcy RL. Quantitative determination of triglycerides by enzymatic endpoint colorimetric method. In: Searcy RL. Diagnostic biochemistry. New York: McGraw Hill; 1969. p. 115-21.
  20. 20. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470-5.10.1093/clinchem/20.4.470
  21. 21. Burstein M, Mortin R. Quantitative determination of HDL-cholesterol using the enzymatic colorimetric method. Life Sci. 1969;8:345-7.10.1016/0024-3205(69)90056-3
  22. 22. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultra-centrifuge. Clin Chem. 1972;18(6):499-502.10.1093/clinchem/18.6.499
  23. 23. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.10.1001/jama.285.19.248611368702
  24. 24. Bilgili SG, Karadag AS, Ozkol HU, Calka O, Akdeniz N. The prevalence of skin diseases among the geriatric patients in eastern Turkey. J Pak Med Assoc. 2012;62(6):535-9.
  25. 25. Kyriakis KP, Terzoudi S, Palamaras I, Michailides C, Emmanuelidis S, Pagana G. Sex and age distribution of patients with lichen planus. J Eur Acad Dermatol Venereol. 2006;20(5):625-6.10.1111/j.1468-3083.2006.01513.x16684307
  26. 26. Bhattacharya M, Kaur I, Kumar B. Lichen planus: a clinical and epidemiological study. J Dermatol. 2000; 27(9):576-82.10.1111/j.1346-8138.2000.tb02232.x11052233
  27. 27. Nakamura R, Broce AA, Palencia DP, Ortiz NI, Leverone A. Dermatoscopy of nail lichen planus. Int J Dermatol. 2013;52(6):684-7.10.1111/j.1365-4632.2011.05283.x23432149
  28. 28. Daoud MS, Gibson LE, Daoud S, el-Azhary RA. Chronic hepatitis C and skin diseases: a review. Mayo Clinic Proc. 1995;70(6):559-64.10.4065/70.6.5597776716
  29. 29. Jubert C, Pawlotsky JM, Pouget F, Andre C, DeForges L, Bretagne S, et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol. 1994;130(1):73-6.10.1001/archderm.1994.01690010077011
  30. 30. Birkenfeld S, Dreiher J, Weitzman D, Cohen AD. A study on the association with hepatitis B and hepatitis C in 1557 patients with lichen planus. J Eur Acad Dermatol Venereol. 2011;25(4):436-40.10.1111/j.1468-3083.2010.03809.x20666875
  31. 31. Song J, Zhang Z, Ji X, Su S, Liu X, Xu S, et al. Lack of evidence of hepatitis in patients with oral lichen planus in China: a case-control study. Med Oral Patol Oral Cir Bucal. 2016;21(2):e161-8.10.4317/medoral.20812478879426827059
  32. 32. Arias-Santiago S, Buendía-Eisman A, Aneiros-Fernández J, Girón-Prieto MS, Gutiérrez-Salmerón MT, Mellado VG, et al. Cardiovascular risk factors in patients with lichen planus. Am J Med. 2011;124(6):543-8.10.1016/j.amjmed.2010.12.02521605731
  33. 33. Arias-Santiago S, Buendía-Eisman A, Aneiros-Fernández J, Girón-Prieto MS, Gutiérrez-Salmerón MT, Garcıa-Mellado V, et al. Lipid levels in patients with lichen planus: a case-control study. J Eur Acad Dermatol Venereol. 2011;25(12):1398-401.10.1111/j.1468-3083.2011.03983.x21348899
  34. 34. Seyhan M, Ozcan H, Sahin I, Bayram N, Karincaoğlu Y. High prevalence of glucose metabolism disturbance in patients with lichen planus. Diabetes Res Clin Pract. 2007;77(2):198-202.10.1016/j.diabres.2006.12.01617275122
  35. 35. Lu R, Zhang J, Sun W, Du G, Zhou G. Inflammation-related cytokines in oral lichen planus: an overview. J Oral Pathol Med. 2015;44(1):1-14.10.1111/jop.1214224329772
  36. 36. Petrou-Amerikanou C, Markopoulos AK, Belazi M, Karamitsos D, Papanayotou P. Prevalence of oral lichen planus in diabetes mellitus according to the type of diabetes. Oral Dis. 1998;4(1):37-40.10.1111/j.1601-0825.1998.tb00253.x9655043
  37. 37. Romero MA, Seoane J, Varela-Centelles P, Diz-Dios P, Garcia-Pola MJ. Prevalence of diabetes mellitus amongst oral lichen planus patients. Clinical and pathological characteristics. Med Oral. 2002;7(2):121-9.
  38. 38. Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes. 2010;59(1):172-81.10.2337/db09-0367279791919794059
  39. 39. Krasowska D, Kozłowicz K, Kowal M, Kurylcio A, Budzyńska-Włodarczyk J, Polkowski W, et al. Twice malignant transformation of hypertrophic lichen planus. Ann Agric Environ Med. 2012;19(4):787-9.
Language: English
Page range: 3 - 12
Submitted on: Mar 5, 2019
Accepted on: Jul 9, 2019
Published on: Nov 12, 2019
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Okpala Chibuzor Ifeanyi, Adeolu Oladayo Akinboro, Ifeanyi Ogochukwu Ezejoifor, Abel N. Onunu, Benson Uchechukwu Okwara, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.